Screener
Chemours CC Equity Method Investments
Equity Method Investments at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Chemours in its filing.
Tagged under the XBRL concept us-gaap:EquityMethodInvestments.
The source filing: Chemours’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 11:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001627223-26-000024
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 270 | 271 |
| Goodwill | 46 | 46 |
| Other intangible assets, net | 2 | 2 |
| Investments in affiliates | 170 | 160 |
| Assets held for sale, non-current | — | 21 |
| Restricted cash and restricted cash equivalents | 52 | 52 |
| Other assets | 488 | 751 |
| Total assets | $7,150 | $7,382 |
Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Chemours's equity method investments?
- Chemours (CC) reported equity method investments of $170M in Q2 2026.
- How has Chemours's equity method investments changed year-over-year?
- Chemours's equity method investments decreased by 4.0% year-over-year, from $177M to $170M.
- What is the long-term trend for Chemours's equity method investments?
- Over 5 years (2020 to 2025), Chemours's equity method investments has grown at a -0.9% compound annual growth rate (CAGR), from $167M to $160M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Chemours's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude